Drugs that lack single-agent activity: are they worth pursuing in combination?

Nat Rev Clin Oncol. 2017 Apr;14(4):193-194. doi: 10.1038/nrclinonc.2017.27. Epub 2017 Mar 7.

Bishal Gyawali¹, Vinay Prasad^{2

3

4}

¹ Department of Haemato-Oncology, Nobel Hospital, Sinamangal, Kathmandu 21034, Nepal.
² Division of Hematology Oncology, Knight Cancer Institute, Oregon Health and Sciences University (OHSU), 3181 South West Sam Jackson Park Road, Portland, Oregon 97239-3098, USA.
³ Department of Public Health and Preventive Medicine, OSHU, 3181 South West Sam Jackson Park Road, Portland, Oregon 97239-3098, USA.
⁴ Center for Ethics in Health Care, OHSU, 3181 South West Sam Jackson Park Road, Portland, Oregon 97239-3098, USA.

No abstract available

MeSH terms